Potent Anti-Diabetic Effects of MHY908, a Newly Synthesized PPAR Α/Γ Dual Agonist in Db/Db Mice

PLoS ONE - United States
doi 10.1371/journal.pone.0078815
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Bavachinin, as a Novel Natural Pan-Ppar Agonist, Exhibits Unique Synergistic Effects With Synthetic PPAR-γ and PPAR-α Agonists on Carbohydrate and Lipid Metabolism in Db/Db and Diet-Induced Obese Mice

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

MicroRNA-29b Inhibits Diabetic Nephropathy in Db/Db Mice

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Differential Effect of Statins on Diabetic Nephropathy in Db/Db Mice

International Journal of Molecular Medicine
MedicineGenetics
2011English

Supplemental Information 1: Establishment of Db/Db Diabetic Mice Model

English

Hypoglycemic and Hypolipidemic Effects of Total Saponins From Stauntonia Chinensis in Diabetic Db/Db Mice

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2018English

Figure 3: Rosiglitazone Administration Increased Wound Angiogenesis in Db/Db Diabetic Mice.

English

Figure 2: Rosiglitazone Administration Accelerated Wound Closure in Db/Db Diabetic Mice.

English

Epiretinal Membranes in a Db/Db Model of Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Figure 4: Rosiglitazone Administration Improved BM-EPC Function in Db/Db Diabetic Mice.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy